Metastatic Hormone-sensitive Prostate Cancer: Current Perspective on the Evolving Therapeutic Landscape

INTRODUCTION: The treatment landscape for patients with metastatic hormone-sensitive prostate cancer (mHSPC) has changed dramatically in the past five years, despite little change in the preceding 20 years. Such rapid change can make it difficult for clinicians to remain abreast of the current liter...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Mary E, Huelster, Heather L, Luckenbaugh, Amy N, Laviana, Aaron A, Keegan, Kirk A, Klaassen, Zachary, Moses, Kelvin A, Wallis, Christopher J D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201221/
https://www.ncbi.nlm.nih.gov/pubmed/32431511
http://dx.doi.org/10.2147/OTT.S228355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201221/
https://www.ncbi.nlm.nih.gov/pubmed/32431511
http://dx.doi.org/10.2147/OTT.S228355

Ejemplares similares